ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666871 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666871; 2) Community: the network communities that were significantly associated with the response to NSC 666871; 3) Molecule: the relationships between components within communities and NSC 666871; 4) MDR: the compounds that were significantly associated with the NSC 666871.

NSC Compound Enrichment Correlation
NSC 682817 7,10:11,14-Dietheno-28H-23,27-nitrilo-22H-dibenzo[b,p] [1,18,5,14]dioxadiazacyclopentacosine 0.0366216145653012 0.090884567
NSC 742036 Null 0.0366216145653012 0.083102985
NSC 743694 Null 0.0366216145653012 -0.047444923
NSC 625495 Antimony, dibromo(1-piperidinecarbodithioato-S,S')-, (T-4)- 0.0366216145653018 -0.024186912
NSC 135929 Null 0.0386895225700407 0.023840764
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0386895225700407 0.24617407
NSC 205555 Butanoic acid, 2,3-dibromo-4-[(5-chloro-2-methoxyphenyl)amino]-4-oxo- 0.0386895225700407 0.07565511
NSC 220334 Replaced CAS registry number(s): 66835-31-2 0.0386895225700407 0.012103525
NSC 285233 Null 0.0386895225700407 -0.15993569
NSC 295501 Camptothecin Derivative 0.0386895225700407 0.27503089
Total:44  Current:32    [First] [Prev] [Next] [Last]